BioAdaptives, Inc. (BDPT)
OTCMKTS · Delayed Price · Currency is USD
0.0177
+0.0016 (9.81%)
Feb 12, 2026, 3:04 PM EST
BioAdaptives Employees
BioAdaptives had 1 employees as of September 30, 2025. The number of employees decreased by 4 or -80.00% compared to the same quarter last year.
Employees
1
Change
-4
Growth
-80.00%
Revenue / Employee
$7,851
Profits / Employee
-$1,106,340
Market Cap
212.31K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2025 | 1 | -4 | -80.00% | 1 | 0 |
| Jun 30, 2025 | 1 | -4 | -80.00% | 1 | 0 |
| Mar 31, 2025 | 1 | -4 | -80.00% | 1 | 0 |
| Sep 30, 2024 | 5 | -1 | -16.67% | 3 | 2 |
| Jun 30, 2024 | 5 | -1 | -16.67% | 3 | 2 |
| Mar 31, 2024 | 5 | -1 | -16.67% | 3 | 2 |
| Dec 31, 2023 | 6 | -1 | -14.29% | 3 | 3 |
| Sep 30, 2023 | 6 | 0 | - | 3 | 3 |
| Jun 30, 2023 | 6 | -1 | -14.29% | 3 | 3 |
| Mar 31, 2023 | 6 | -1 | -14.29% | 3 | 3 |
| Dec 31, 2022 | 7 | 0 | - | 3 | 4 |
| Sep 30, 2022 | 6 | -1 | -14.29% | 3 | 3 |
| Jun 30, 2022 | 7 | - | - | 3 | 4 |
| Mar 31, 2022 | 7 | - | - | 3 | 4 |
| Dec 31, 2021 | 7 | - | - | 3 | 4 |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
BioAdaptives News
- 4 months ago - BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing - GlobeNewsWire
- 6 months ago - BioAdaptives' MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety - GlobeNewsWire
- 7 months ago - BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience - GlobeNewsWire
- 8 months ago - BioAdaptives Announces National Launch of Pawpa™ Regen - GlobeNewsWire
- 9 months ago - BioAdaptives® PawPa™ Regen Provides Breakthrough Stem Cell Support for Pets, Backed by Clinically Proven APBAR® Scale Improvements - GlobeNewsWire
- 1 year ago - Zeranovia(TM) Weight Loss Product Shows Promising Results in Dosage Trial - GlobeNewsWire
- 1 year ago - BioAdaptives Welcomes UFC Senior Executive Reed Harris to Its Board of Advisors - GlobeNewsWire
- 1 year ago - BioAdaptives Welcomes Mark Frissora, Acclaimed Business Leader, to Its Board of Directors - GlobeNewsWire